Cardioprotection through a reduction in cardiac CapZ
通过减少心脏 CapZ 来保护心脏
基本信息
- 批准号:267386
- 负责人:
- 金额:$ 19.14万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Operating Grants
- 财政年份:2012
- 资助国家:加拿大
- 起止时间:2012-09-01 至 2015-09-01
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In heart failure, cardiac muscle contraction is negatively altered by a family of molecules called "Protein Kinase C" (PKC). We found that reducing CapZ protein blocks PKC-dependent inhibition of contraction. We hypothesized that reducing CapZ protects he
在心力衰竭中,心肌收缩被称为“蛋白激酶C”(PKC)的分子家族负面改变。我们发现,减少CapZ蛋白阻断PKC依赖的收缩抑制。我们假设减少CapZ可以保护他
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Pyle Glen W其他文献
Pyle Glen W的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Pyle Glen W', 18)}}的其他基金
Getting to the Heart of Domestic Abuse: Identifying the molecular mechanisms of heart disease in association with physical and psychological stress
深入了解家庭暴力的核心:确定心脏病与身体和心理压力相关的分子机制
- 批准号:
486978 - 财政年份:2023
- 资助金额:
$ 19.14万 - 项目类别:
Operating Grants
Cardioprotection through manipulation of CapZ
通过操纵 CapZ 实现心脏保护
- 批准号:
420302 - 财政年份:2020
- 资助金额:
$ 19.14万 - 项目类别:
Operating Grants
Sex and the Ageing Heart: The molecular basis for the functional decline and development of a novel therapeutic target
性与衰老的心脏:功能衰退的分子基础和新型治疗靶点的发展
- 批准号:
339909 - 财政年份:2015
- 资助金额:
$ 19.14万 - 项目类别:
Operating Grants
相似海外基金
Alterations in macrophage metabolism in heart failure with preserved ejection
射血保留性心力衰竭患者巨噬细胞代谢的改变
- 批准号:
502586 - 财政年份:2024
- 资助金额:
$ 19.14万 - 项目类别:
SBIR Phase II: In-vivo validation of a volume-manufacturable and factory-calibrated wearable NT-proBNP monitoring system for heart failure treatment
SBIR II 期:用于心力衰竭治疗的可批量生产和工厂校准的可穿戴 NT-proBNP 监测系统的体内验证
- 批准号:
2335105 - 财政年份:2024
- 资助金额:
$ 19.14万 - 项目类别:
Cooperative Agreement
RAPHAEL - Integrating a Palliative Care Approach for Patients with Heart Failure
RAPHAEL - 为心力衰竭患者整合姑息治疗方法
- 批准号:
10112701 - 财政年份:2024
- 资助金额:
$ 19.14万 - 项目类别:
EU-Funded
Trustworthy Artificial Intelligence for Personalised Risk Assessment in Chronic Heart Failure
值得信赖的人工智能,用于慢性心力衰竭的个性化风险评估
- 批准号:
10078557 - 财政年份:2023
- 资助金额:
$ 19.14万 - 项目类别:
EU-Funded
Elucidating the Intricate Interplay between Mitochondria, Innate Immunity, and Viral Pathogenesis in Heart Failure
阐明心力衰竭中线粒体、先天免疫和病毒发病机制之间复杂的相互作用
- 批准号:
491149 - 财政年份:2023
- 资助金额:
$ 19.14万 - 项目类别:
Fellowship Programs
Comparison of Machine Learning and Conventional Statistical Modeling for Predicting Readmission Following Acute Heart Failure Hospitalization
机器学习与传统统计模型预测急性心力衰竭住院后再入院的比较
- 批准号:
495410 - 财政年份:2023
- 资助金额:
$ 19.14万 - 项目类别:
Exploratory research to elucidate the molecular mechanisms by which depression makes heart failure more severe and to reconstruct heart failure treatment strategies.
探索性研究旨在阐明抑郁症使心力衰竭更加严重的分子机制,并重建心力衰竭治疗策略。
- 批准号:
23K07507 - 财政年份:2023
- 资助金额:
$ 19.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Aging of cardiac fibroblasts and heart failure: novel heart failure treatment through regeneration and transplantation of cardiac fibroblasts
心脏成纤维细胞的衰老和心力衰竭:通过心脏成纤维细胞的再生和移植治疗心力衰竭
- 批准号:
23K07526 - 财政年份:2023
- 资助金额:
$ 19.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Advanced fluorescence spectroscopy to unravel functional oligomerization of a newly discovered Ca2+ channel and its role in heart failure.
先进的荧光光谱揭示了新发现的 Ca2 通道的功能性寡聚及其在心力衰竭中的作用。
- 批准号:
2885854 - 财政年份:2023
- 资助金额:
$ 19.14万 - 项目类别:
Studentship
Elucidation of the precise mechanism of heart failure prevention by beta-catenin inhibition enabling the future development of a novel class of medicine
阐明β-连环蛋白抑制预防心力衰竭的精确机制,有助于未来开发一类新型药物
- 批准号:
23K15167 - 财政年份:2023
- 资助金额:
$ 19.14万 - 项目类别:
Grant-in-Aid for Early-Career Scientists